BONESUPPORT (Q2 Initial take): In line with expectations but modest guidance change - Redeye

The deviation in Q2 was relatively insignificant, but the company's comments on lower-than-expected sales growth in Q2, together with a slight change to its 2026e constant currency sales growth target, are likely to weigh on the share today by a few percentage points.

Länk till analysen i sin helhet: https://www.redeye.se/research/1174887/bonesupport-q2-initial-take-in-line-with-expectations-but-modest-guidance-change?utm_source=finwire&utm_medium=RSS